Mechanism of SARS-CoV-2 polymerase stalling by remdesivir
Remdesivir is a nucleoside analog that inhibits the SARS-CoV-2 RNA dependent RNA polymerase (RdRp) and is used as a drug to treat COVID19 patients. Here, the authors provide insights into the mechanism of remdesivir-induced RdRp stalling by determining the cryo-EM structures of SARS-CoV-2 RdRp with...
Saved in:
Main Authors: | Goran Kokic, Hauke S. Hillen, Dimitry Tegunov, Christian Dienemann, Florian Seitz, Jana Schmitzova, Lucas Farnung, Aaron Siewert, Claudia Höbartner, Patrick Cramer |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/8b3f1fceaaca4cfa95f1314132c6731b |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The structure of a dimeric form of SARS-CoV-2 polymerase
by: Florian A. Jochheim, et al.
Published: (2021) -
Structural basis of TFIIH activation for nucleotide excision repair
by: Goran Kokic, et al.
Published: (2019) -
Structure of transcribing RNA polymerase II-nucleosome complex
by: Lucas Farnung, et al.
Published: (2018) -
Allosteric Activation of SARS-CoV-2 RNA-Dependent RNA Polymerase by Remdesivir Triphosphate and Other Phosphorylated Nucleotides
by: Bing Wang, et al.
Published: (2021) -
Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease
by: Maria L. Agostini, et al.
Published: (2018)